Medicare Enrolled

Dr. Roshan Patel, M.D.

Rheumatology · Covina, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
500 W SAN BERNARDINO RD STE A, Covina, CA 91722
6269661909
In practice since 2016 (9 years)
NPI: 1457709131 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Roshan Patel is a rheumatology specialist in Covina, CA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,971 Medicare services across 653 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $10,978 from 36 pharmaceutical and/or device companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 37% volume in CA $10,978 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,971
Medicare services
Top 37% in CA for rheumatology
653
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~219 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,028 $17 $55
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
183 $104 $250
Autoimmune disorder antibody test
A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders.
122 $18 $50
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
101 $11 $23
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
87 $121 $380
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
53 $13 $25
Rheumatoid factor level 53 $6 $15
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
48 $29 $80
X-ray of hand, 2 views
An X-ray imaging test of the hand using two different angles to visualize the bones and joints.
47 $26 $90
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
37 $45 $240
Knee X-ray, 1-2 views
An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures.
30 $31 $90
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
28 $50 $195
Injection, methylprednisolone acetate, 40 mg 24 $6 $15
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
22 $12 $60
Measurement of dna antibody, single stranded 20 $12 $35
Microsomal antibody test
A blood test that measures the level of microsomal antibodies, which are autoantibodies produced by the immune system.
20 $14 $60
Thyroglobulin antibody blood test
A blood test that measures the level of antibodies against thyroglobulin, a protein produced by the thyroid gland.
20 $16 $60
DNA antibody test (native or double-stranded)
A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body.
19 $13 $45
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
15 $35 $120
Tuberculosis blood test (gamma interferon)
A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels.
14 $61 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,978
Total received (2019-2024)
Avg $2,196/year across 5 years
Top 27% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
448
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,842 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$136 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,975
2023
$4,049
2022
$1,876
2021
$54
2019
$24

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$858
GlaxoSmithKline, LLC.
$553
ABBVIE INC.
$491
Amgen Inc.
$337
Novartis Pharmaceuticals Corporation
$310
UCB, Inc.
$310
Radius Health, Inc.
$236
Mallinckrodt Hospital Products Inc.
$221
Organon Llc
$214
Alexion Pharmaceuticals, Inc.
$175
Fresenius Kabi USA, LLC
$169
COLOPLAST CORP
$148
AstraZeneca Pharmaceuticals LP
$134
Novo Nordisk Inc
$122
SANOFI-AVENTIS U.S. LLC
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
ANI Pharmaceuticals, Inc.
$89
Lilly USA, LLC
$75
GENZYME CORPORATION
$64
SCILEX PHARMACEUTICALS INC.
$54
Currax Pharmaceuticals LLC
$53
E.R. Squibb & Sons, L.L.C.
$53
Merck Sharp & Dohme LLC
$31
SOBI, INC
$28
PFIZER INC.
$27
Aurinia Pharma U.S., Inc.
$16
Kyowa Kirin, Inc.
$16
Top 3 companies account for 38.2% of 2024 payments
All-time payments by company (2019-2024) ›
ABBVIE INC.
$1,448
Janssen Biotech, Inc.
$1,378
Amgen Inc.
$1,306
Novartis Pharmaceuticals Corporation
$1,034
UCB, Inc.
$926
GlaxoSmithKline, LLC.
$917
AstraZeneca Pharmaceuticals LP
$448
Mallinckrodt Hospital Products Inc.
$418
Alexion Pharmaceuticals, Inc.
$395
Radius Health, Inc.
$286
Fresenius Kabi USA, LLC
$225
Organon Llc
$214
Horizon Therapeutics plc
$210
Aurinia Pharma U.S., Inc.
$164
PFIZER INC.
$159
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
COLOPLAST CORP
$148
Novo Nordisk Inc
$122
Lilly USA, LLC
$117
Cumberland Pharmaceuticals, Inc.
$107
E.R. Squibb & Sons, L.L.C.
$106
SANOFI-AVENTIS U.S. LLC
$99
Currax Pharmaceuticals LLC
$92
ANI Pharmaceuticals, Inc.
$89
GENZYME CORPORATION
$64
Organon LLC
$61
SOBI, INC
$54
SCILEX PHARMACEUTICALS INC.
$54
Celltrion USA Inc.
$37
Merck Sharp & Dohme LLC
$31
JAZZ PHARMACEUTICALS INC.
$24
AbbVie Inc.
$22
Pacira Pharmaceuticals Incorporated
$20
Kyowa Kirin, Inc.
$16
IMPEL PHARMACEUTICALS INC.
$16
Hikma Pharmaceuticals USA
$13
Top 3 companies account for 37.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Altis · BENLYSTA · BRIDION · Bimzelx · CONTRAVE · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · EVUSHELD · Enbrel · HADLIMA · ILARIS · Iovera · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · Mitigare · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · REDITREX · REMICADE · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · SUNOSI · TALTZ · TAVNEOS · TREMFYA · Tavneos · Trudhesa · ULTOMIRIS · Wegovy · XELJANZ · YUFLYMA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Covina?
Compare rheumatologists in the Covina area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
108
Per 100K population
1.1
County median income
$87,760
Nearest hospital
EMANATE HEALTH INTER-COMMUNITY HOSPITAL
1.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Patel performed 1,028 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $10,978 from 36 companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other rheumatologists in Covina?
Dr. Patel's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →